Nguyen
01-20-2023, 11:43 AM
Wonder if this would work after T-DxD.
https://www.astrazeneca.com/media-centre/press-releases/2022/datopotamab-deruxtecan-showed-encouraging-and-durable-efficacy-in-patients-with-metastatic-breast-cancer.html
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive, HER2-low or negative metastatic breast cancer
https://www.astrazeneca.com/media-centre/press-releases/2022/datopotamab-deruxtecan-showed-encouraging-and-durable-efficacy-in-patients-with-metastatic-breast-cancer.html
Datopotamab deruxtecan showed encouraging and durable efficacy in patients with heavily pretreated HR-positive, HER2-low or negative metastatic breast cancer